IL13 and hepatocellular carcinoma: Transwell and MTT assays demonstrated that the proliferation, migration, and invasion capabilities of liver carcinoma cells were augmented by IL‐4 and IL‐13 contrasted with the DMSO control group, whereas PLX3397 weakened these abilities (Figure 5D–F).